Can a support program help reduce chemsex complications?
Part of Infections clinical trials.
This trial tests a community support program called PARC for people who engage in chemsex. It aims to see if the program helps reduce or stop drug use and related health problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man who has sex with men, or you are non-binary, or you are a trans man or woman connected to gay sexual networks.
- You have used cathinones, methamphetamine, or GHB/GBL for chemsex at least twice.
- You are looking for help to reduce or stop your chemsex use.
- You have been referred to the PARC program for this reason.
- You have a health condition that is not well controlled (like a physical or mental health issue).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-painful brain stimulation method (tDCS) to help reduce cravings related to chemsex. If you qualify, you’ll be randomly assigned to real stimulation or a sham (placebo) and complete study visits and questionnaires.
This study tests a new support program designed specifically for transgender people who use drugs or engage in chemsex (using drugs during sexual activity). The program aims to reduce health risks and provide safer, more culturally respectful care.
This study explores how adding conversation about sexual pleasure to harm reduction services can help men who have sex with men and transgender persons who use drugs during sex or use other substances. If you join, you may learn new ways to reduce risks while still enjoying your sex life.
This study looks at substance use patterns in people who practice chemsex. It aims to better understand how to help those affected.
This study explores ways to support men who have sex with men (MSM) in Bangkok who use drugs during sexual activities, called 'chemsex.' Researchers want to understand how community leaders, healthcare workers, and police can work together to keep people safer and healthier.
This study tests if a long-acting HIV treatment shot, called Cabenuva, works well for people who use drugs like methamphetamine or GHB during sex. It may help make treatment easier for those who find daily pills challenging.
Hear when a new Chemsex trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.